Molecule Details
InChIKeyBOOOLEGQBVUTKC-NVQSDHBMSA-N
Compound NameVtp-194204
Canonical SMILESCC(/C=C/[C@@H]1C[C@]1(C)c1ccc2c(c1)C(C)(C)CCC2(C)C)=C\C(=O)O
Clinical Status Data-mined Candidate
Targets (Human+Pathogen)3
Pfam Stratification Homologous
Avg pChEMBL8.75
SourceChEMBL;BindingDB
2D Structure
2D structure
Activity Profile
DrugBank Annotations
DrugBank ID DB11806
Drug NameVTP-194204
CAS Number220619-73-8
Groups investigational
ATC Codes nan
DescriptionNrx194204 has been used in trials studying the treatment of Parkinson's Disease and Non-small Cell Lung Cancer.
Categories: Fatty Acids Ligands Lipids Naphthalenes
Cross-references: BindingDB: 50101445 CHEMBL75133 ChemSpider: 8039037 PubChem:9863341 PubChem:347828153 ZINC: ZINC000001550770
Target Activities (3)
Target Gene Organism Category Pfam pChEMBL Type Source
P19793 RXRA Homo sapiens Human PF00104 PF11825 PF00105 9.4 Kd ChEMBL;BindingDB
P28702 RXRB Homo sapiens Human PF00104 PF00105 8.4 Kd ChEMBL;BindingDB
P48443 RXRG Homo sapiens Human PF00104 PF11825 PF00105 8.4 Kd ChEMBL;BindingDB
DrugBank Target Actions (1)
Target Gene Target Name Action Type
P48443 RXRG Retinoic acid receptor RXR-gamma modulator targets